Skip to content

Welcome to Discover Pharma! Today is : November 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical & Regulatory

  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    PhaseV and Crohn’s & Colitis Foundation join forces to fast-track IBD clinical trials with AI

    A new collaboration aims to tackle the toughest challenges in [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    myTomorrows unveils new SaaS platform to streamline global expanded access programs

    Health tech company myTomorrows has launched a dedicated platform to [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    ScaleReady awards multiple G-Rex grants to USC and Children’s Hospital of Los Angeles Investigators

    ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development

    BioIVT and Handok Biotech form exclusive partnership to support research innovation in South Korea

    BioIVT, a global provider of biospecimen solutions for drug and [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data

    How AI and risk-based models are shaping the future of clinical trials

    In this post-Clinical Trials Day spotlight, Ken McFarlane, VP of [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Manufacturing & Supply Chain

    CellProthera taps CELLforCURE by SEQENS for phase 3 production of heart attack cell therapy

    First clinical batches of ProtheraCytes expected in 2026 CellProthera has [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Opinion & Events

    Poolbeg receives FDA Orphan Drug Designation for POLB 001

    Poolbeg Pharma has been granted Orphan Drug Designation (ODD) by [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain

    ITM secures $262.5M financing from Blue Owl to drive US launch of radiopharmaceutical for neuroendocrine tumors

    Landmark debt deal enables commercial readiness for ITM-11, supports pipeline [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data

    Clinical trial innovation hampered by change fatigue and skills gaps, survey finds

    A new survey from eClinical Solutions reveals that biopharma organizations [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain

    Lonza launches Design2Optimize platform to accelerate API development

    Lonza has unveiled a new model-based development platform, Design2Optimize, which [...]

    May 5, 2026
Previous737475Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Enterome data link CD8 T-cell expansion to progression-free survival in lymphoma
    Categories: Advanced Therapies, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Telix starts Phase 3 trial of radiopharmaceutical therapy for renal cancer
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
  • Deep Origin computational platform identifies potent molecular glue for lymphoma treatment
    Categories: Digital & Data, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top